Peter WT Pisters, M.D., president of The University of Texas MD Anderson Cancer Center, was honored today with the Charles M.

Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently ...

The former 'Entertainment Tonight' co-host revealed in 2015 that he had been diagnosed with a rare form of prostate cancer ...

IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.

John Tesh says he has outlived a terminal cancer prognosis by nearly eight years while continuing treatment for metastatic ...

The study analyzed data from more than 1.8 million people for 16 years ...

Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non-small cell lung cancer (NSCLC) and ...

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

How can I deliver care not just to the 100,000 patients who might have cancer but to the 500,000 patients who may be at risk of cancer?” That question is shaping the early tenure of Anirban Maitra, MD ...

John Tesh says he considers it a miracle that he is still alive after being diagnosed with a rare form of cancer nearly a ...

Cooper University Health Care is a leading academic health system with more than 8,500 employees and more than 800 employed ...

John Tesh has revealed details of his long battle with a rare form of cancer, saying he was initially told he might have only 18 months to live. The former Entertainment Tonight host and musician, now ...